The Prognostic Significance of Premature Ventricular Complexes in Patients Without Structural Heart Disease
NCT ID: NCT03370679
Last Updated: 2018-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1000 participants
OBSERVATIONAL
2013-09-30
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognosis in Adult Patients with Congenital Heart Disease
NCT06723704
Evaluation of Hemodynamic Changes of the Left Ventricle Following the Use of Extracorporeal Circulation
NCT03922178
Use of POC Pocket Ultrasound in the Estimation of Left and Right Atrial Pressures
NCT03897647
Diastolic Dysfunction PPCM in Patients With Documented Left Ventricular Systolic Function Recovery
NCT04143997
Right Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease
NCT03471936
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* in study one the investigators include patients who are evaluated because of PVCs and have no signs of structural heart disease at echocardiography and exercise test. The investigators follow them (average follow-up time 3,5 years) to investigate if they have a higher mortality och cardiovascular morbidity than standard population
* in study two the investigators carry out a sub-group analysis of the population in study one to assess whether PVC:s different sites of origin (morphology) are related to the clinical outcome
* in study three the investigators include persons with a high PVC-burden (at least 10 000 PVC:s/day) and normal echocardiography. The included subjects undergo magnetic resonance (MR) to investigate whether it can identify signs of heart disease where standard echocardiography cannot
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Undergone coronary arterty bypass grafting (CABG)
* Finding of Heart Failure at echocardiography
* Direct or indirect findings of coronary ischaemia at exercise test, coronary angiography or other equivalent examination
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danderyd Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raffaele Scorza, MD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet - Danderyd Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HjÀrtkliniken Danderyds Sjukhus
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PULSE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.